<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Selegiline; Selegiline; Selegiline; Eldepryl; Zelapar; Selegiline" /><meta name="IX" content="Selegiline; Selegiline; Eldepryl; Zelapar; Selegiline" /><meta name="IXM" content="Selegiline" /><title>SELEGILINE HYDROCHLORIDE: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3116-selegiline-hydrochloride.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3116-selegiline-hydrochloride.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3116-selegiline-hydrochloride.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP3054-drugs-used-in-parkinsonism-and-related-disorders.htm">4.9 Drugs used in parkinsonism and related disorders</a> &gt; <a href="PHP3056-dopaminergic-drugs-used-in-parkinsons-disease.htm">4.9.1 Dopaminergic drugs used in Parkinson's disease</a> &gt; <a href="PHP3113-monoamine-oxidase-b-inhibitors.htm">Monoamine-oxidase-B inhibitors</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3114-rasagiline.htm" title="Previous: RASAGILINE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3117-selegiline-hydrochloride-non-proprietary.htm#PHP3117-selegiline-hydrochloride-non-proprietary" title="Next: Selegiline Hydrochloride">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a397046.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Antiparkinsonian Agents 28:36 &gt; Monoamine Oxidase B Inhibitors 28:36.32</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20595-x.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Selegiline</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: S &gt; Interactions of Selegiline</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="PHP3113-monoamine-oxidase-b-inhibitors.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Monoamine-oxidase-B inhibitors</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson's disease</p></div></li><li><a href="PHP3117-selegiline-hydrochloride-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline Hydrochloride</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson's disease &gt; Monoamine-oxidase-B inhibitors &gt; SELEGILINE HYDROCHLORIDE</p></div></li><li><a href="PHP3118-eldepryl.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Eldepryl®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson's disease &gt; Monoamine-oxidase-B inhibitors &gt; SELEGILINE HYDROCHLORIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22selegiline+hydrochloride%22%22selegiline%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1492.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; S</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0018s0047.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; S</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/13228-v.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiparkinsonian Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/08428.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; S &gt; SE</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-S13.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline Hydrochloride</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; S</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E22E3E0R0D653.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Selegiline</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; S</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c338.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Selegiline hydrochloride</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; S</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>SELEGILINE HYDROCHLORIDE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int687-selegiline.htm">Selegiline</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">Parkinson's disease, used alone or as adjunct to co-beneldopa or co-careldopa; symptomatic parkinsonism</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">avoid abrupt withdrawal; gastric and duodenal ulceration (avoid in active ulceration), uncontrolled hypertension (and avoid drugs that increase blood pressure), arrhythmias, angina, psychosis (and patients predisposed to confusion and psychosis), side-effects of levodopa may be increased—concurrent levodopa dosage can be reduced by 10–30% in steps of 10% every 3–4 days; history of hepatic dysfunction; avoid in acute porphyria (<a title="BNF:sub-section: Acute porphyrias" href="PHP6363-acute-porphyrias.htm">section 9.8.2</a>); <strong>interactions: </strong>Appendix 1 (selegiline)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">use with caution in severe impairment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">use with caution in severe impairment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">avoid—no information available</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">avoid—no information available</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">nausea, constipation, diarrhoea, dry mouth, stomatitis, mouth ulcers, bradycardia, hypertension, hypotension, depression, dizziness, psychosis, impaired balance, tremor, fatigue, movement disorders, sleeping disorders, headache, confusion, arthralgia, myalgia, muscle cramps, myopathy, nasal congestion, hair loss, sweating; <em>less commonly</em> loss of appetite, angina, arrhythmias, palpitation, postural hypotension, supraventricular tachycardia, ankle oedema, dyspnoea, agitation, anxiety, micturition difficulties, leucocytopenia, thrombocytopenia, blurred vision; skin reactions; <em>also reported</em> hypersexuality</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Initially 5 mg in the morning; increasing after 2–4 weeks if tolerated to 10 mg in the morning</p></li>  </ul><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">1.25-mg oral lyophilisate is equivalent to 10-mg tablet</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP3117-selegiline-hydrochloride-non-proprietary.htm#PHP3117-selegiline-hydrochloride-non-proprietary" title="Selegiline Hydrochloride">Selegiline Hydrochloride</a></li><li><a href="PHP3118-eldepryl.htm#PHP3118-eldepryl" title="Eldepryl®">Eldepryl®</a></li><li id="_PHP3119-oral-lyophilisate_PHP3119-oral-lyophilisate"><a href="PHP3119-oral-lyophilisate.htm#PHP3119-oral-lyophilisate" title="Oral lyophilisate">Oral lyophilisate</a><ul style="display: none"><li><a href="PHP3120-zelapar.htm#PHP3120-zelapar" title="Zelapar®">Zelapar®</a></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3114-rasagiline.htm">Previous: RASAGILINE</a> | <a class="top" href="PHP3116-selegiline-hydrochloride.htm#">Top</a> | <a accesskey="]" href="PHP3117-selegiline-hydrochloride-non-proprietary.htm#PHP3117-selegiline-hydrochloride-non-proprietary" title="Selegiline Hydrochloride">Next: Selegiline Hydrochloride</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>